Ritika Tyagi

Ritika Tyagi

I consult businesses as a Corporate Communicator where I help companies about the growth of the healthcare market.

Followers 5
Following 0
The Preparative and process chromatography market size is expected to reach USD 8.60 billion by 2023 from the estimated USD 6.27 billion in 2018, at a CAGR of 6.5%.The major factors driving the growth of this market are the increasing prevalence of appendicitis and growing preference for R investments in biotechnology and pharmaceutical companies.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=151748164Process chromatography type is expected to account for the larger market share in 2018.By type, the preparative and process chromatography market is classified into process chromatography and preparative chromatography.The process chromatography segment is estimated to command the larger market share in 2018.This is mainly due to increasing production of vaccines and monoclonal antibodies in biotechnology and pharmaceutical industries.Biotechnology & pharmaceutical industries segment is expected to account for the largest share of the preparative and process chromatography market in 2018.By end user, the preparative chromatography market segmented into biotechnology & pharmaceutical industries, food & nutraceutical industries, and academic institutes.In 2018, the biotechnology & pharmaceutical industries segment is estimated to account for the largest market share.
The global gas chromatography (GC) market study involved the extensive use of both primary and secondary sources.The research process involved the study of various factors affecting the industry to identify the segmentation types, key players, competitive landscape, key market dynamics, and key strategies.Major Growth Drivers: The growth in this market is driven by the increasing adoption of GC-MS, rising crude & shale oil production, increasing importance of wastewater treatment, rising food safety concerns, and growing use of chromatography tests in the drug approval process.However, the high cost of GC equipment, geopolitical issues prevailing in some countries, and shortage of skilled professionals are expected to restrain the growth of this market during the forecast period.Expected Revenue Growth:  The global GC market size is projected to reach USD 3.5 billion by 2025 from USD 2.8 billion in 2020, at a CAGR of 4.1%.Accessories to Fuel the Growth of  GC market :In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report.The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the GC market.The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations.Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=101656773“Adoption of GC systems is expected to increase during the forecast period.”The systems segment of the GC instruments market is expected to account for the highest growth due to factors such increased capability to analyze complex compounds.“The columns segment will grow at the highest rate during the forecast period.”On the basis of accessories and consumables, the GC market is divided into columns, columns accessories, autosampler accessories, flow management accessories, consumables & accessories, fittings & tubing, pressure regulators, gas generators, and other accessories.
Medication errors and dispensing errors are recognized as leading causes of hospital readmissions across the globe.A medication error can occur due to a variety of factors such as poor order communication between the physician and pharmacist, dangerous storage practices in pharmacies, and confusion arising out of the use of similar labels.Automated systems are considered to be one of the most efficient solutions to minimize these errors.Major Growth Drivers: The major factors that are expected to be driving the pharmacy automation market are the growing need to minimize medication errors, rapid decentralization of pharmacies, rising geriatric population and rising labor cost.On the other hand, reluctance among the healthcare organizations to adopt pharmacy automation systems is expected to restrain the overall market growth to a certain extent during the forecast period.The objective of the report is to define, describe, and forecast the pharmacy automation market size based on product, end user, and region.Expected Revenue Growth: MarketsandMarkets forecasts the pharmacy automation market is estimated to grow from USD 3.63 billion in 2017 to USD 5.38 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 8.2% during the forecast period.Accessories to Fuel the Growth of pharmacy automation market  :Based on product, the pharmacy automation market is segmented into automated medication dispensing systems, automated packaging and labelling systems, automated table top counters, automated medication compounding systems, automated storage and retrieval systems, and other pharmacy automation systems.Automated medication dispensing systems accounted for the largest share of the pharmacy automation market in 2016.
The key trends for increase in market, by public health organization are the growing expenditure on drugs and medical devices by public health organizations, steps by the government to build up strong analytical testing abilities, increasing number of drug approvals and clinical trials, and rising demand for specialized analytical testing services.However, complex and innovative pharmaceutical products requiring a distinctive analytical testing approach is the major challenge hampering the growth of government support.Major Growth Drivers: The overall market, by public health organization is positively impacted by factors such as the growing expenditure on drugs and medical devices by public health organizations, government initiatives to strengthen analytical testing capabilities, increasing number of drug approvals & clinical trials, and rising demand for specialized analytical testing services.However, complex and innovative pharmaceutical products requiring a distinctive analytical testing approach is the major challenge hampering the growth of government support on analytical laboratory services.Expected Revenue Growth:The global analytical laboratory services market, by public health organization is projected to reach USD 333.8 Million by 2021 from USD 202.8 Million in 2016, at a CAGR of around 10.5% during the forecast period.Accessories to Fuel the Growth of  analytical laboratory services market :On the basis of type of service, the spend assessment is segmented into eight segments, namely, bioanalytical testing, batch release testing, stability testing, raw material testing, physical characterization, method validation, microbial testing, and environmental monitoring.In 2015, the bioanalytical testing segment accounted for the largest share of the analytical laboratory services market, by public health organization.This growth can be attributed to factors such as the usage and development of a large number of macromolecules and Biosimilars for various therapeutic areas and the growing biopharmaceutical industry across the globe.The spending on batch release testing services is expected to account for the second largest share during the forecast period.Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65590498On the basis of type of service, the spend assessment is segmented into eight segments, namely, bioanalytical testing, batch release testing, stability testing, raw material testing, physical characterization, method validation, microbial testing, and environmental monitoring.The spending on batch release testing services is expected to account for the second largest share during the forecast period.The growth can be attributed to the need for checking and validating the process for product development among pharmaceutical & biopharmaceutical companies and the increasing usage of dissolution test in the development and approval of generic solid oral dosage forms.Geographically, the analytical laboratory services market, by public health organization is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
The study involved four major activities in estimating the current size of the global non-invasive prenatal testing market.Exhaustive secondary research was done to collect information on the market, its peer markets, and its parent market.The next step was to validate these findings, assumptions, and sizing values with industry experts across the value chain through primary research.Both top-down and bottom-up approaches were employed to estimate the complete market size.Major Growth Drivers:Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT.However, a dearth of skilled professionals is restraining the growth of this market.Expected Revenue Growth:The global non-invasive prenatal testing (NIPT) market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period.Accessories to Fuel the Growth of Non Invasive Prenatal Testing (NIPT) Market:By method, the NIPT products market is segmented into ultrasound detection, biochemical screening tests, and cell-free DNA in maternal plasma tests.The high growth of this segment is attributed to technological advancements and increasing company initiatives to develop new products.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690The trisomy applications segment accounted for the largest share of the global NIPT market in 2018.Based on application, the non-invasive prenatal testing (NIPT) market is segmented into trisomy, microdeletion syndrome, and other applications (gender identification and the detection of monogenic disorders, Klinefelter syndrome, and Rhesus (Rh) blood type).
This study involved four major activities in estimating the current size of the anatomic pathology market.The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.Both top-down and bottom-up approaches were employed to estimate the complete market size.Major Growth Drivers:The growth in this market is majorly driven by the high incidence of cancer and other target diseases, availability of reimbursement, and the growing focus on personalized medicine.However, the availability of refurbished products, the lack of skilled professionals, and product recalls are expected to hamper the market growth to a certain extent during the forecast period.Expected Revenue Growth:The global anatomic pathology market size is estimated to grow from USD 33.3 billion in 2020 to USD 46.8 billion by 2025, at a CAGR of 7.1%.Accessories to Fuel the Growth of Anatomic Pathology Market :Globally, the COVID-19 outbreak has impacted every aspect of the diagnostics industry, including the anatomic pathology market.In the last few months, the number of patient visits to hospitals has reduced significantly, despite emergency and OPD services being available in hospitals.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145Cancer is a complex disease that develops through the multi-stage carcinogenesis process involving multiple pathways.It is a vital part of anatomic pathology since the accurate diagnosis of cancer and other diseases usually requires the histopathological examination of samples.Services segment to witness the highest growth during the forecast periodBy product & service, the anatomic pathology market is segmented into services, instruments, and consumables.
Top-down and bottom-up approaches were used to validate the size of the global Healthcare BPO market and estimate the size of various other dependent submarkets.Major players in the market were identified through secondary research and their market revenues were determined through primary and secondary research.Secondary research included the study of the annual and financial reports of top market players, whereas primary research included extensive interviews with key opinion leaders such as CEOs, directors, and marketing executives.Major Growth Drivers:In the current market scenario, there is a growing demand for healthcare BPO services.The objective of this report is to define, describe, and forecast the market on the basis of outsourcing services including payer, provider, and pharmaceutical services and region.It provides detailed information regarding the major factors influencing the growth of healthcare outsourcing market.Expected Revenue Growth:Healthcare BPO market is estimated to grow at a CAGR of 10.2% from 2017 to 2022 to reach $312.43 billion by 2022 from $191.68 billion in 2017.Accessories to Fuel the Growth of Healthcare BPO Market :Based on provider services, the Healthcare BPO market is segmented into revenue cycle management, patient enrolment & strategic planning, and patient care.Growth in the revenue cycle management market can largely be attributed to factors such as decreasing reimbursements in the healthcare industry, reductions in the overall healthcare costs, initiatives undertaken by governments for implementing RCM solutions, and increasing expenditure by the Healthcare IT industry.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=472Based on payer services, the Healthcare BPO market is segmented into claims management, integrated front-end services and back-office operations, member management, product development & business acquisition, provider management, care management, billing & accounts management services, and HR services.
This study involved the extensive use of both primary and secondary sources.The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.Major Growth Drivers:In the current regulatory climate-where the focus on sustainable techniques has risen—it is expected that the benefits of cold plasma will ensure its greater adoption in the years to come.Innovations in textile production and growing food safety concerns are the major factors driving the growth of this market.Expected Revenue Growth:The global cold plasma market size is projected to reach USD 3.4 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 16.0%.Accessories to Fuel the Growth of Cold Plasma Market :The cold plasma market is expected to be significantly impacted by the Covid-19 pandemic in 2020-2021.However, there could be possible disruptions in the industries such as textile, electronics & semiconductors, polymer & plastic, food & agriculture, and medical during the period of lockdown and movement restrictions imposed globally to control the virus spread and flatten the curve.Social distancing protocols and quarantine measures have reduced the demand for textiles, apparels, semiconductors & electronic appliances, large scale farming practices, and the non essential services has been put off till the post lockdown period .Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=187065928The wound healing segment is projected to grow at the highest CAGR during the forecast periodWithin the medical industry, the cold plasma market is segmented into wound healing, dentistry, oncology, blood coagulation, and other applications.The wound healing segment is projected to grow at the highest growth rate during the forecast period, driven by the advantages of cold plasma treatment, along with the minimal side-effects, thus making it more viable over conventional methods.Low-pressure cold plasma to witness the highest growth during the forecast periodBased on the regime, the cold plasma market is classified broadly into atmospheric cold plasma and low-pressure plasma.The low-pressure cold plasma is estimated to hold the largest share of the market in 2019 and is also projected to grow at the highest rate during the forecast period.
The report "Hemostats Market by Product (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Gynecology, Neurology, Cardiovascular, Reconstructive), Formulation (Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2023", The hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%.Growth in this market is driven by the increasing number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries.In addition, the emerging markets and growth in the number of hospitals and surgical centers are expected to offer further growth opportunities for players operating in the hemostats market.On the other hand, high cost of hemostats and dearth of skilled professionals are expected to hinder the growth of this market.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=9571619The thrombin-based hemostats segment is expected to account for the largest share of the market in 2018.Based on product, the hemostats market is segmented into thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats.Of all these product segments, the thrombin-based hemostats segment is expected to account for the largest share of the global hemostats market in 2018.In 2018, the orthopedic surgery segment is expected to dominate the hemostats market On the basis of application, the hemostats market is segmented neurological surgery, cardiovascular surgery, general surgery, orthopedic surgery, gynecological surgery, reconstructive surgery, and other surgeries.The orthopedic surgery segment is expected to account for the largest share of the hemostats market in 2018.In 2018, North America to command for the largest market share On the basis of region, the hemostats market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.In 2018, North America is expected to account for the largest share of the global hemostats market.
The report segments the market based on product, technology, type, site of delivery, applications, end user and regions.Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors.The jet-based needle-free injectors are expected to witness the highest growth during the forecast period, due to their advantages over the other injector systems.Major Growth Drivers:Major factors driving the growth of this market include growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices.On the other hand, high development cost of needle-free injection system over the conventional needle injection may hinder the growth of this market during the forecast period.Expected Revenue Growth:The global needle-free injection system market, in terms of value, is projected to reach USD 20.17 Billion by 2021 from USD 9.81 Billion in 2016, at a CAGR of 15.5% during the forecast period.Accessories to Fuel the Growth of Needle-Free Injection System Market :Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861Based on the technology, the market is divided into Jet-based needle-free injectors, spring-based needle-free injectors, laser-based needle-free injectors and vibration-based needle-free injectors.The jet-based needle-free injector is expected to account for the largest market share in 2016, due to their advantages over the other injector systems.Based on the Applications, the market is segmented into vaccine delivery, insulin delivery, Oncology, pain management and other applications; the vaccine delivery application segment is projected to be the fastest-growing segment during forecast period in 2016.The growth of this market primarily attributed to factors such as the rising incidence of chronic diseases, technological advancement, and growing preference for self-medication.North America is expected to dominate the market in 2016, with the U.S. accounting for a major share.However, Europe is expected to grow at the highest CAGR during the forecast period.
Pressure monitoring plays an important role in detecting the health problems of a patient.The major fluctuations of pressure in the vital areas of the body may cause various chronic and acute diseases such as diabetes, cardiac arrest, and glaucoma.Increase in the prevalence of the above mentioned diseases and growing aging population have increased the need for pressure monitoring and control in the market.Expected Revenue Growth:The overall market for pressure monitoring is expected to reach $8,040.6 million by 2020 from $6,000.0 million in 2015, growing at a CAGR of 5.0% from 2015 to 2020.Factors such as rising prevalence of chronic and acute diseases increase in the aging population, new product launches, and technological advancements are driving the growth of this market.On the other hand, high cost of technological advancements, lack of trained professionals, accuracy of the devices and short shelf life is hindering the growth of this market.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=196787732Pressure monitoring plays an important role in detecting the health problems of a patient.Increase in the prevalence of the above mentioned diseases and growing aging population have increased the need for pressure monitoring and control in the market.The major factors responsible for the growth of the pressure monitoring are the rising prevalence of chronic and acute diseases, growth of aging population, new product launches, increase in the lifestyle related diseases, and technological advancements.Due to these factors, the demand for pressure monitoring is increasing.
2
The global healthcare asset management market is projected to reach USD 35.19 billion by 2023 from USD 8.98 billion from 2018, at a CAGR of 31.4%.Need for better asset management in hospitals, acceptance of asset management solutions in pharmaceutical industry, and decline in prices of RFID Tags are the factors driving the growth of the healthcare asset management market.RFID Tags segment is expected to dominate the RFID products market in 2018.Based on type, the healthcare asset management market is segmented into tags, readers/interrogators, antennas, and accessories.In 2018, the RFID tags segment is expected to dominate the market.The growth of this market is attributed to the increasing acceptance of RFID in pharmaceutical companies, declining prices of RFID tags, and the availability of technologically advanced products in the market.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1195Based on type, the passive RFID tag segment is projected to grow at the highest CAGR during the forecast period.Based on type, RFID tags market is segmented into passive tags and active tags.In 2018, the passive RFID segment is expected to account for the largest share of the market; also, this segment is expected to register highest CAGR during the forecast period owing to the low cost of passive tags in comparison with active tags.Also, passive tags do not require an external source of energy, owing to which they are more widely adopted.North America to dominate the healthcare asset market in 2018 In 2018, North America is expected to dominate the hospital asset management market followed by Europe.
The global cell counting market is projected to reach USD 14.5 billion in 2025 from USD 10.4 billion in 2020, at a CAGR of 6.7 % during the forecast period.Cell Counting Market growth is largely driven by factors such as growing funding for cell-based research, rising incidence of chronic and infectious diseases, growing biotechnology and biopharmaceutical industries, the development of enhanced solutions and improved image analysis, and the growing use of high-throughput flow cytometry and automated hematology analyzers.On the other hand, the high cost of cell analysis is expected to hinder market growth to a certain extent.By application, the research application segment accounted for the largest share of the cell counting market On the basis of application, the cell counting market is segmented into research, medical, and industrial applications.In 2019, research applications accounted for the largest share of the market.Increasing government initiatives in stem cell research and the wide usage of cell counting in research are the major factors driving the growth of the research applications segment.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157450728By end user, the research institutes segment accounted for the largest share of the cell counting market On the basis of end users, the cell counting market is segmented into research institutes, hospitals & diagnostic laboratories, pharmaceutical & biotechnology companies and CROs, and other end users.In 2019, research institutes accounted for the largest share of the market.The large share of this segment can primarily be attributed to the growing regulatory approvals for cell culture-based vaccines, increasing pharmaceutical R expenditure, and commercial expansion of various pharmaceutical companies.By region, North America accounted for the largest share of the cell counting market In 2019, North America accounted for the largest share of the cell counting consumables market, followed by Europe.The large share of the North American market can be attributed to the increasing demand for technologically advanced instruments in research and diagnostic applications and the high prevalence of target conditions, coupled with the increasing demand for early and effective disease diagnosis and treatment.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=157450728Leading Players The major companies in the cell counting market include Danaher Corporation (US), Thermo Fisher Scientific Inc. (US), Becton, Dickinson and Company (US), Merck KGaA (Germany), and Bio-Rad Laboratories (US)
Growth in this market is driven majorly by the rising R spending in the pharmaceutical & biopharmaceutical industry, growing demand for membrane filtration technology, increasing purity requirements in end-user segments, and growing focus on developing large-molecule biopharmaceuticals.Laboratory filtration market size is projected to reach USD 4.1 billion by 2025 from USD 2.5 billion in 2019, at a CAGR of 8.3% during the forecast period.Laboratory filtration market by Product (Filtration Assembly, Filter Media Accessories), Technology (Ultrafiltration, Microfiltration, Nanofiltration, RO), End User (Pharmaceutical, Biopharmaceutical Company, F), Region.The study involved four major activities in estimating the current size of the laboratory filtration market.Exhaustive secondary research was conducted to collect information on the market as well as its peer and parent markets.The next step was to validate these findings, assumptions, and sizes with industry experts across the value chain through primary research.Download PDF [email protected] : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12936082The filtration media segment accounted for the largest share of the market, by product, in 2018Based on product, the market is segmented into filtration media (filter papers, membrane filters, syringe and syringeless filters, filtration microplates, and other filtration media), filtration assemblies (microfiltration assemblies, reverse osmosis assemblies, ultrafiltration assemblies, vacuum filtration assemblies, and other filtration assemblies), and filtration accessories (filter holders, filter funnels, filter flasks, membrane dispensers, filter housings, cartridges, vacuum pumps, seals, and other filtration accessories).The microfiltration segment accounted for the largest share of the market, by technique, in 2018Based on technique, the market is segmented into microfiltration, ultrafiltration, reverse osmosis, vacuum filtration, and nanofiltration.The microfiltration segment accounted for the largest share in 2018, while the ultrafiltration segment is projected to witness the highest growth during the forecast period.Rising R activities in the pharma industry and wide applications in the food & beverage industry are the key factors boosting the growth of this market segment.Region Covered in Laboratory Filtration Market :The global lab filtration market is segmented into five major regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
Growth in the overall market can largely be attributed to factors such as increasing advancements in wireless communication technologies, growing internet penetration, increasing utilization of connected devices in the management of chronic diseases, rising adoption of a patient-centric approach by healthcare providers, robust penetration of 3G and 4G networks in healthcare services, and mainstreaming of cloud computing.The report segments the market of wireless health based on technologies, components, applications, end users, and regions.What This Report Will Provide:Wireless health is expected to transform the existing traditional and paper-based healthcare systems, ensuring quality care along with patient safety.Wireless health solutions can help reduce healthcare costs, streamline workflows in healthcare systems, and facilitate compliance with regulatory guidelines.The global market is segmented on the basis of technologies, components, applications, and end users.The global market is projected to reach USD 110.12 Billion by 2020 from USD 39.03 Billion in 2015, at a CAGR of 23.1% during the forecast period.The market is expected to be dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW).The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period.Download PDF [email protected] https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=551Technology :On the basis of technology, the market of wireless health is further segmented into WPAN, WLAN/WiFi, WiMAX, and WWAN.The WPAN technology market segment accounts for the largest share in the market in 2015.WPAN technologies are highly secure and affordable, making them one of the most widely adopted wireless health technologies.
The global real-world evidence market is projected to reach USD 1,348.1 million by 2023 from USD 689.9 million in 2018, at a CAGR of 14.3% during the forecast period.The growth of real-world evidence market is majorly driven by the rising geriatric population (and the subsequent increase in the prevalence of chronic diseases), shift from volume- to value-based care, and delays in drug development (and the subsequent increase in development costs).By component, the data sets segment accounted for the largest share of the real world evidence market in 2017.On the basis of component, the data sets segment accounted for the largest share of the global real world evidence market.The large share can be attributed to factors such as easy availability of massive amounts of data, increasing dependence of outcome-based studies on real-world data, and rising demand for information by payers and providers regarding drug safety.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134046412By therapeutic area, the oncology segment held the largest market share of the real world evidence solutions market in 2017.Based on therapeutic area, the oncology segment accounted for the largest share of the real world evidence solutions market in 2017.The large share of this segment can be attributed to the high number of clinical trials conducted for oncology and the rising prevalence of cancer worldwide.North America dominated the real world evidence solutions market in 2017North America accounted for the largest share of the real world evidence market in 2017, followed by Europe and Asia Pacific.Presence of a favorable regulatory environment, high number of RWE service providers, the presence of a well-established pharmaceutical industry in the region, coupled with the high R expenditure, are the major factors responsible for the large share of North America in the global real world evidence market.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=134046412Leading CompaniesIQVIA (US), ICON (Ireland), PAREXEL (US), Pharmaceutical Product Development (US), Optum (US), International Business Machines Corporation (US), Cognizant (US), Oracle (US), SAS (US), Syneos Health (US), Anthem (US), Clinigen Group (UK), Palantir Technologies (UK), and Flatiron Health (US).
The major factors driving the growth of slide stainer market include the increasing incidence of chronic diseases, rising geriatric population, growing automation in laboratories, and increasing healthcare expenditure.The slide stainers market is expected to reach USD 4.70 billion by 2023 from an estimated USD 2.79 billion in 2018, at a CAGR of 11.0%.By product, the reagents segment accounted for the largest share of the slide stainers market in 2017On the basis of product, the reagents segment accounted for the largest share of the global slide stainers market in 2017.The large share of this segment is attributed to the rising prevalence of chronic and infectious diseases, increasing healthcare expenditure, increasing public awareness, and growing demand for automation in diagnostics and clinical research.Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134046412By technology, the hematoxylin & eosin (H) segment held the largest share in 2017 Based on technology, the automated slide stainers market is segmented into hematoxylin and eosin (H), immunohistochemistry, in situ hybridization, cytology, microbiology, hematology, and special stains.In 2017, the H segment accounted for the largest share of the slide stainers market.North America dominated the slide strainers and accessories market in 2017 North America accounted for the largest share of the slide stainers and accessories market in 2017, followed by Europe and Asia Pacific.The highly developed healthcare system in this region, the easy accessibility to technologically advanced instruments, and the presence of major key players in the region are the major factors responsible for the large share of the North American automated slide stainers market.Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=134046412Leading CompaniesRoche (Switzerland), Agilent (US), Danaher (US), BioGenex (US), Thermo Fisher Scientific (US), Sakura (Japan), Biocare Medical (US), Merck Group (Germany), General Data Company (US), and Hardy Diagnostics (US).
The objective of the report is to define, describe, and forecast the empty capsules market size based on type, functionality, application, end user, and region.[206 Pages Report] MarketsandMarkets forecasts the Empty Capsules market to grow from USD 1.95 billion in 2018 to USD 2.79 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 7.4% during the forecast period.Gelatin is the original and most common material used to produce capsules.However, gelatin is an animal by-product formed from collagen, obtained from the by-products of slaughtered animals including the bones, hides, and hooves of cattle, pigs, horses, fish, and poultryDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218018190Among the type of capsules segment, the non-gelatin capsules segment is expected to grow at the highest CAGR during the forecast period.The increasing demand for non-animal-based products and the advantages offered by these capsules over gelatin-based ones, such as low hygroscopicity, physical stability, stability in different ranges of temperature & humidity, and low moisture content are driving the segment growth.The immediate-release capsules segment is expected to witness a faster growth rate in this market, as they are widely used for the manufacture of antibiotics, antibacterials, antacids, painkillers, inhalators, cold and cough drug preparations, and dietary supplements.Also, immediate-release capsules are the most commonly prescribed capsules to treat a wide range of diseases and disorders.The dietary supplements segment is expected to witness a faster growth rate in this market.Factors such as increased health awareness and rising affordability in emerging countries (such as India, China, and Brazil), increasing prevalence of lifestyle diseases, and increasing use of vitamin capsules due to their availability as over-the-counter (OTC) drugs are contributing to the growth of this segment.Geographical growth scenario of Empty Capsules Market :North America is expected to hold the largest market size in the empty capsules market during the forecast period, followed by the European region.
The increasing demand for next-generation sequencing, the growing significance of companion diagnostics in drug development, and the rising number of clinical trials are the major factors driving the growth of this market.The companion diagnostics market is expected to reach USD 6.8 billion by 2025 from USD 3.7 billion in 2020, at a CAGR of 12.9% during the forecast period of 2020 to 2025.Companion Diagnostics Market by Product & Service (Assay, Kit, Software & Service), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Lung & Gastric Cancer, Neurological Disease), End-User (Pharma Companies, CRO).Advantages of companion diagnostics, the growing need for targeted therapy, the rising importance of personalized medicine, the increasing global incidence of cancer, and the ever-increasing application areas of companion diagnostics are driving the growth of the global companion diagnostics industry.Opportunities: Increasing Demand For Next-generation SequencingNGS-based companion diagnostic tests aim to unlock molecular information from each patient’s tumor genome to guide treatment decisions for cancer therapies.The use of NGS panels for biomarker measurement in one test has the potential to help in the treatment of many different types of cancers.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155571681Challenges: Shortage Of Trained ProfessionalsCompanion diagnostic testing is a complex and technical process that demands well-trained resources.The knowledge of companion diagnostic technologies is vital for effectively carrying out tests.CDx assays are sensitive to the quantity and purity of the samples used, and small deviations can lead to erroneous and variable inferences.In addition, different types of assays, kits, tests, and software & services are used in companion diagnostics; this increases the cost of production.
1
The growth of the global refurbished medical equipment market can be attributed to factors such as hospital budget cuts, a large inventory of used or old medical devises, rising demand for capital-intensive diagnostic imaging equipment, e-commerce platform enhancing the ease of purchase of refurbished medical equipment, growing preference for eco-friendly products, an increasing number of diagnostic centers & hospitals, and the growing opportunities in emerging economies.The global refurbished medical equipment market is projected to reach USD 21.2 billion by 2025 from USD 12.1 billion in 2020, growing at a CAGR of 11.8% from 2020 to 2025.Refurbished Medical Equipment Market by Product (Medical Imaging, Intensive Care Equipment, OR Equipment, Patient Monitors), Application (Cardiology, Neurology, Urology, Oncology), End User (Hospitals, Diagnostic Imaging Centers).However, factors such as stringent regulations on the import and use of refurbished medical devices in certain countries, lack in the standardization of policies for the use & sale of refurbished devices, increase in the influx of low-cost new medical devices, and the negative perception about the quality of refurbished medical devices are expected to restrain the market growth.Furthermore, the growth of the market is expected to be slowed temporarily due to the COVID-19 pandemic during the forecast period.Refurbished medical equipment market is segmented into medical imaging equipment, operating room & surgical equipment, patient monitors, cardiology equipment, urology equipment, neurology equipment, intensive care equipment, endoscopy equipment, IV therapy systems, and other medical equipment.The medical imaging equipment segment was estimated to account for the highest share in 2019.The large share of this segment can be attributed to factors such as the presence of a large number of products under this segment and their high utility in the healthcare and clinical space, the ability of this equipment to last for many years, growing demand for early disease diagnosis and non-invasive diagnostic imaging, a growing number of hospitals as well as diagnostic imaging centers across the world, and the budget constrains to purchase new equipment among end users.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=770Based on procedure, the refurbished medical equipment market is segmented into diagnostic and therapeutic procedures segments.The rising demand for diagnostic imaging procedures, the high price of new medical imaging equipment, a growing number of target diseases, widening application of diagnostic imaging procedures, regulatory approvals in using refurbished medical equipment, low purchasing power in emerging economies, and established & government validated refurbishment processes adopted by major OEMs are factors expected to drive the growth of this market segment in the coming years.Based on end users, the global refurbished medical equipment market has been segmented into hospitals, ambulatory surgical centers, diagnostic imaging centers, and other end users.The rising adoption of refurbished medical equipment, increasing focus of hospitals on providing affordable treatment and care, and growing emphasis on high returns on investment are some of the key factors driving the growth of this market.Region Covered in Refurbished Medical Equipment Market.Geographically, this market is classified into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
More

Top